The biotech investor’s bible
An investment consultant, formerly a journalist who reported on the emergence of recombinant DNA technology, discusses the maturing biotech sector from new investment strategy and scientific/ technological perspectives. Appendices include a breakdown of 185 major biotech companies by market cap and...
Сохранить в:
| Главный автор: | |
|---|---|
| Формат: | |
| Язык: | Undetermined |
| Опубликовано: |
New York
John Wiley & Sons
2001
|
| Предметы: | |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|
| Thư viện lưu trữ: | Trung tâm Học liệu Trường Đại học Cần Thơ |
|---|
| Итог: | An investment consultant, formerly a journalist who reported on the emergence of recombinant DNA technology, discusses the maturing biotech sector from new investment strategy and scientific/ technological perspectives. Appendices include a breakdown of 185 major biotech companies by market cap and tier, resources, and a glossary of biotech terms. |
|---|